secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2026-04-08T23:59:59+00:00
Accession:  0001193125-26-147660
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA pro forma 2025 net loss $34.6M after Kineta acquisition; exec bonuses approved
--------------------------------------------------------------------------------

- Pro forma net loss attributable to common stockholders $34.57M, or $(0.64) per share, for year ended Dec 31, 2025.
- Kineta merger closed June 30, 2025; Kineta shareholders received ~3.998M TuHURA shares (7.6% post-merger ownership).
- Concurrent June 2025 private placement raised $11.5M net from 4.76M shares and warrants at $2.65/unit.
- CEO Bianco awarded $490,536 bonus; new salary $605,956. CFO Dearborn awarded $163,393 bonus; new salary $403,676.
- No cash consideration paid at closing due to Kineta working capital deficit of $5.255M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526147660/0001193125-26-147660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526147660/d131347d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-147660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer